Annual Operating Expenses
$29.63 M
-$1.01 M-3.29%
31 December 2023
Summary:
Moleculin Biotech annual total operating expenses is currently $29.63 million, with the most recent change of -$1.01 million (-3.29%) on 31 December 2023. During the last 3 years, it has risen by +$9.89 million (+50.09%). MBRX annual operating expenses is now -3.29% below its all-time high of $30.64 million, reached on 31 December 2022.MBRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$7.13 M
+$950.00 K+15.36%
30 September 2024
Summary:
Moleculin Biotech quarterly total operating expenses is currently $7.13 million, with the most recent change of +$950.00 thousand (+15.36%) on 30 September 2024. Over the past year, it has increased by +$1.19 million (+19.98%). MBRX quarterly operating expenses is now -21.46% below its all-time high of $9.08 million, reached on 30 September 2022.MBRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MBRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | +20.0% |
| 3 y3 years | +50.1% | +15.9% |
| 5 y5 years | +97.2% | +58.3% |
MBRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -3.3% | +50.1% | -21.5% | +37.1% |
| 5 y | 5 years | -3.3% | +97.2% | -21.5% | +104.2% |
| alltime | all time | -3.3% | +663.1% | -21.5% | +2122.7% |
Moleculin Biotech Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.13 M(+15.4%) |
| June 2024 | - | $6.18 M(-7.4%) |
| Mar 2024 | - | $6.68 M(-25.1%) |
| Dec 2023 | $29.63 M(-3.3%) | $8.92 M(+50.0%) |
| Sept 2023 | - | $5.95 M(-7.2%) |
| June 2023 | - | $6.41 M(-23.3%) |
| Mar 2023 | - | $8.35 M(+18.5%) |
| Dec 2022 | $30.64 M(+33.4%) | $7.05 M(-22.4%) |
| Sept 2022 | - | $9.08 M(+22.2%) |
| June 2022 | - | $7.43 M(+5.1%) |
| Mar 2022 | - | $7.07 M(+35.9%) |
| Dec 2021 | $22.97 M(+16.3%) | $5.21 M(-15.5%) |
| Sept 2021 | - | $6.16 M(+11.6%) |
| June 2021 | - | $5.52 M(-9.4%) |
| Mar 2021 | - | $6.09 M(+74.2%) |
| Dec 2020 | $19.74 M | $3.50 M(-43.2%) |
| Sept 2020 | - | $6.15 M(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $5.03 M(-0.6%) |
| Mar 2020 | - | $5.06 M(+5.2%) |
| Dec 2019 | $17.52 M(+16.6%) | $4.81 M(+6.8%) |
| Sept 2019 | - | $4.51 M(+24.1%) |
| June 2019 | - | $3.63 M(-20.5%) |
| Mar 2019 | - | $4.57 M(+5.4%) |
| Dec 2018 | $15.03 M(+73.6%) | $4.34 M(+67.4%) |
| Sept 2018 | - | $2.59 M(-52.5%) |
| June 2018 | - | $5.46 M(+107.0%) |
| Mar 2018 | - | $2.64 M(-22.3%) |
| Dec 2017 | $8.65 M(+122.8%) | $3.39 M(+41.1%) |
| Sept 2017 | - | $2.40 M(+82.1%) |
| June 2017 | - | $1.32 M(-14.0%) |
| Mar 2017 | - | $1.53 M(+8.3%) |
| Dec 2016 | $3.88 M | $1.42 M(-0.4%) |
| Sept 2016 | - | $1.42 M(+96.4%) |
| June 2016 | - | $724.00 K(+125.5%) |
| Mar 2016 | - | $321.00 K |
FAQ
- What is Moleculin Biotech annual total operating expenses?
- What is the all time high annual operating expenses for Moleculin Biotech?
- What is Moleculin Biotech annual operating expenses year-on-year change?
- What is Moleculin Biotech quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Moleculin Biotech?
- What is Moleculin Biotech quarterly operating expenses year-on-year change?
What is Moleculin Biotech annual total operating expenses?
The current annual operating expenses of MBRX is $29.63 M
What is the all time high annual operating expenses for Moleculin Biotech?
Moleculin Biotech all-time high annual total operating expenses is $30.64 M
What is Moleculin Biotech annual operating expenses year-on-year change?
Over the past year, MBRX annual total operating expenses has changed by -$1.01 M (-3.29%)
What is Moleculin Biotech quarterly total operating expenses?
The current quarterly operating expenses of MBRX is $7.13 M
What is the all time high quarterly operating expenses for Moleculin Biotech?
Moleculin Biotech all-time high quarterly total operating expenses is $9.08 M
What is Moleculin Biotech quarterly operating expenses year-on-year change?
Over the past year, MBRX quarterly total operating expenses has changed by +$1.19 M (+19.98%)